In Depth 2 Apr 2025
Beyond amyloid: The search for the next big thing in Alzheimer’s treatment
Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer’s disease treatments.
Gene therapy
- Latest Posts
In Depth 24 Jan 2025
Why are there only 20 cell and gene therapies in Europe?
There are 20 cell and gene therapies on Europe’s market versus 43 in the U.S. Find out more about this ecosystem.
Best in Biotech 16 Jan 2025
Ten first-in-class drugs on track for FDA approval in 2025
As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval in 2025.
In Depth 13 Jan 2025
2025 predictions: Which trends are set to shape the biotech industry this year?
From AI to gene therapy, we reached out to industry experts to get their thoughts on the trends that will shape the biotech industry in 2025.
News and Trends 10 Jan 2025
The in vivo revolution: How Interius, Umoja, and Vyriad are transforming CAR-T cell therapy
A U.S. trial of an in vivo CAR gene therapy has expanded to Europe, marking the first-ever trial of its kind in the region.
In Depth 25 Dec 2024
When biotech makes Christmas miracles a reality
Explore how biotech breakthroughs in 2024 have changed lives, bringing real Christmas miracles to patients and offering hope for the future.
ADVERTISEMENT
ADVERTISEMENT
In Depth 27 Nov 2024
Charcot–Marie–Tooth disease: what’s going on in the clinical field?
In this article, we take a look at the various treatments in development to address the unmet needs of people with Charcot–Marie–Tooth disease.
In Depth 21 Nov 2024
Huntington’s disease: a therapeutic field on a bumpy ride
For years, biotechs have been trying to develop medicines to cure the disease but much to no avail. Now, as clinical studies advance, there is hope.
Best in Biotech 21 Nov 2024
Eight areas where gene therapy shines
Delve into the numerous applications of gene therapy, from cancer to hematological disorders and respiratory diseases.
In Depth 11 Nov 2024
Gene editing sector investment struggles: What’s driving the slowdown?
Find out what is driving the slowdown in gene therapy investment, as the sector continues to struggle with widespread layoffs.
Best in Biotech 7 Nov 2024
Cystic fibrosis: Five biotechs breathing life into the therapeutic space
In this article, we take a look at five biotechs developing potentially transformative medicines to treat this genetic disease.
Unlocking AAV gene therapy potential: The role of successful characterization
Explore the role and challenges of AAV characterization, the significance of capsid filling, and the best methods to enhance gene therapy.
ADVERTISEMENT
